Lili leads the bioinformatics team in Montreal, developing computational strategies to identify and prioritize tumor-specific antigens for cancer vaccines.

She brings expertise in (epi)genomics and ML-driven bioinformatics, and is passionate about translating complex data into actionable insights.

Lili studied Chemistry at Imperial College London and earned a fully funded PhD in cancer epigenomics from the Francis Crick Institute and UCL.

Following a brief postdoctoral position, she joined a clinical-stage biopharmaceutical company developing T cell therapies targeting clonal neoantigens. 

Born in Montreal, she spent 15 years in the UK before returning home—bringing a uniquely transatlantic perspective to Epitopea’s UK–Canada team.